Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
LQWD Technologies Lightning Network Infrastructure Surpasses 1 Million Global Transactions (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Grace Therapeutics, Inc GRCE

Healthcare
Grace Therapeutics, Inc., formerly Acasti Pharma Inc., is a late-stage biopharma company with drug candidates addressing rare and orphan diseases. Its therapeutic pipeline consists of three clinical-stage drug candidates supported by an intellectual property portfolio of over 40 granted and pending patents in various jurisdictions. Its lead drug candidate, GTX-104, is a clinical-stage, novel... see more

Recent & Breaking News (NDAQ:GRCE)

Acasti Pharma Announces Positive Results for Pharmacokinetic Bridging Study, With Intravenous GTX-104 Meeting All Endpoints

GlobeNewswire May 18, 2022

Update: Acasti Pharma CEO to Present at Microcap Rodeo's Spring into Action Best Ideas Virtual Conference on May 18th

Accesswire May 16, 2022

36 of the Best Ideas Companies to Present at the Spring into Action - Best Ideas Investor Conference on May 16th - 20th, 2022

Accesswire May 16, 2022

Acasti Pharma CEO to Present at Microcap Rodeo's Spring into Action Best Ideas Virtual Conference on May 16th

Accesswire May 12, 2022

Acasti Pharma to Present at the B. Riley Securities' 2022 Virtual Neuro & Ophthalmology Conference on April 28th

GlobeNewswire April 25, 2022

Acasti Pharma (TSXV:ACST) appoints Michael L. Derby to its Board of Directors

Brieanna McCutcheon  March 25, 2022

Acasti Pharma Appoints Healthcare Industry Leader Michael L. Derby to its Board of Directors

GlobeNewswire March 25, 2022

Acasti Pharma (TSXV:ACST) receives three international patents for its drug candidates

Caroline Egan  March 22, 2022

Acasti Pharma Announces Patents for GTX-104 in Europe, GTX-102 in the U.S. and GTX-101 in Japan

GlobeNewswire March 22, 2022

Acasti Pharma CEO to Present at the 32nd Annual Oppenheimer Healthcare Conference on March 16th

GlobeNewswire March 9, 2022

Acasti Pharma Celebrates Rare Disease Day

GlobeNewswire February 28, 2022

Acasti Pharma Inc. CEO, Jan D'Alvise, Is Featured on The Stock Day Podcast

Newsfile February 22, 2022

Acasti Pharma Provides Business Update for the Third Quarter of Fiscal 2022

GlobeNewswire February 14, 2022

Acasti Pharma Schedules Third Quarter Fiscal 2022 Business Update Conference Call

GlobeNewswire February 7, 2022

Acasti Pharma to Present at the H.C. Wainwright BioConnect 2022 Conference

GlobeNewswire January 3, 2022

Acasti Pharma Announces Interim Data Meets All Primary Endpoints for Pivotal PK Study for GTX-104

GlobeNewswire December 2, 2021

Acasti Pharma CEO to Participate in the Benzinga All Access Event on December 2nd

GlobeNewswire November 24, 2021

Acasti Pharma Announces Annual Stock Option Grants

GlobeNewswire November 12, 2021

Acasti Pharma To Present At The Q4 Investor Summit on November 16th

Newsfile November 11, 2021

Acasti Pharma Provides Business Update for the Second Quarter of Fiscal 2022

GlobeNewswire November 10, 2021